Participants in the highest tertile of healthy dietary scores showed a trend of negative associations with type I CRC (adjusted OR = 0.52, 95% CI = 0.25–1.11; p = 0.054 for trend) and a strong negative association with type II CRC (adjusted OR = 0.19, 95% CI = 0.07–0.48; p < 0.001 for trend) ( Table 3 ).
Tumor size between 5 and 10 cm was significantly associated with poorer CSS (HR = 2.89, P = 0.004), while tumors ≥10 cm showed a trend toward worse survival (HR = 2.14, P = 0.054).
Interestingly, testosterone showed a trend to increase power in the beta band ( p = 0.054) and did in the gamma band ( p = 0.045).
Functional independence An improvement in FIM total score from baseline to month 6 occurred in the ITB arm (+2.68 (10.31)), while a worsening occurred in the CMM arm (−2.58 (11.00)) ( table 3 and figure 3 ); the analysis showed a trend towards a treatment effect in favour of ITB over CMM (P=0.0540).
In the unadjusted model decreased FEV 1 showed a trend toward a relation with the occurrence of cGvHD ( P = 0.107, not shown), which became almost significant in the adjusted model ( Table 3 ; P = 0.054).
Patients with mMRC grade 1 showed a trend towards a higher risk of exacerbation in GOLD A groups (p=0.054) and a significantly increased risk of exacerbation in GOLD B (p<0.0001) compared with patients with mMRC grade 0. 58 In GOLD A/B groups with a high prevalence of mMRC grade 1, patients had significantly lower pulmonary function (p<0.0
The PFS showed a trend in favour of arm A (log-rank P = 0.054).
Instead, the levels showed a trend toward reduction (p = 0.054), suggesting that demand for serine as a 1C donor may be increased.
Additionally, that group also showed a trend to elevated levels in relation to the Sham + GbE ( p = 0.054) and OVX ( p = 0.075) groups.
Healing status was significantly associated with OS in univariable analysis (HR 0.52, p = 0.021) and RFS showed a trend ( p = 0.054) in the same direction.
When conducting ANOVA at individual time points, only the 3-month period showed a trend (p = 0.054) for the same Stress*Dye interaction.
Hyponatremic CRS patients showed a trend for a higher in-hospital mortality (15.6% versus 7.6%, p = 0.054), but no difference in the one-year mortality (43.3% versus 40.1%, p = 0.692).
In quartile analysis, compared with the first quartile, the fourth quartile showed a trend toward increased DR risk (OR: 1.60, 95% CI: 0.99–2.59, P = 0.054), with a significant dose-response trend (P for trend = 0.040).
The main effect of Emotion showed a trend, F (3, 87) = 2.64, p = .054, η 2 = .08.
Regarding complications, there were no significant differences in the occurrence of ≥Grade III Clavien–Dindo complications, while the Comprehensive Complication Index (CCI) showed a trend toward higher values in the older group (mean of 22.9 vs. 16, p = 0.054).
The interaction of lesion group x surgery for the subjective values (V1 RL ) showed a trend for significance (p=0.054) ( Figure 3—figure supplement 1 ).
Similarly, BMI showed a trend towards higher values in Group 2 ( p = 0.054).
However, the colocalization of GnRH and vGluT2 punta density only showed a trend for a decrease (P = 0.054) that, together with the different ages at which GnRH (young to old) and vGluT2 (young to MA) decreased, suggests that the age-related decline of vGluT2 in the median eminence was probably not associated specifically with the GnRH system.
In line with this, the PD-1+ cell number also showed a trend to a positive correlation with CD8+ cells (r=0.311, p=0.054), while no correlation was observed with the remaining markers (p>0.05).
Whereas miR-221 overexpressing LNCaP cells showed a trend towards higher cell viability ( p = 0.054), the comparison between TRAIL-treated LNCaP cells after pre-miR-221 or control transfections was statistically significant (119.5 ± 19.7% vs. 84.8 ± 5.6%, p = 0.013).
Nonetheless, exposed females also showed a trend towards significance for increased CD36 protein expression levels ( p =0.054), compared to their sex-matched controls.
After controlling for batch/age/BMI, the differences between the groups showed a trend towards statistical significance (adjusted p = 0.054), and the SPMS group showed the highest levels of expression.
Similarly, guselkumab showed a trend towards superiority over adalimumab for hands and/or feet psoriasis (82.9% vs. 61.5%, p = 0.054).
When tumour size was dichotomized using the median value as the cut-off, larger tumours showed a trend towards a slightly poorer oxygenation status, but only regarding the mean pO 2 ( P =0.054).
While patients with 1MT in PIK3CA/AKT1 showed a trend toward better iDFS than patients with WT PIK3CA/AKT1 (p=0.054) ( Fig. 1C ), the OS of patients with 1MT in PIK3CA/AKT1 was not significantly different than in patients with WT PIK3CA/AKT1 ( Fig. 1D ). 2) ER-positive patients (210 cases) Regarding the PIK3CA gene, no significant difference in iDFS was observed among ER+ patients with WT, 1MT, and 2MTs in PIK3CA ( Fig. 2A ).